Abstract:Background: Celiac Disease (CD) is an immune-mediated disorder, in which the HLA immunogenetic background (DQ2 and DQ8 heterodimers) and environmental trigger (gluten) are well established. Indeed, both factors are necessary - but not sufficient - to develop CD. However, it is very likely that CD is underdiagnosed in both developing and developed countries, due to several aspects, including the fact that a lot of patients present mild and/or atypical symptoms, without the presence of any recognized risk factors. Therefore, the possibility and feasibility of widened screening strategies to identify CD patients are debated. Aim: To provide further evidence of the main epidemiological importance of HLA-DQB1*02 allele in the population of CD patients. Methods: We performed a systematic search in PubMed, EMBASE, Cochrane, Web of Science and Scopus databases, in order to produce a systematic review assessing the carrier frequency of HLA-DQB1*02 allele in the celiac population. Following the PRISMA guidelines, we retrieved all the original articles describing CD patients' HLA-DQB1 genotype in such a way that could allow to assess the HLA-DQB1*02 carrier frequency among CD patients, along with the evidence of the appropriate diagnostic work-up to achieve a correct and final diagnosis of CD. Results: The final output of this systematic search in the medical literature consisted of 38 studies providing the appropriate HLA-DQB1 genotype information of the respective CD population. According to this systematic review, including a pool of 4945 HLA-DQ genotyped CD patients, the HLA-DQB1*02 carrier frequency was 94.94%, meaning that only 5.06% of CD patients were completely lacking this allelic variant. Interestingly, if we consider only the studies whereby the prevalence of CD patients affected with type 1 diabetes mellitus was supposed or clearly established to be very low, the frequency of non-HLA-DQB1*02 carriers among CD patients dropped to 3.65%. Conclusion: Such a high carrier frequency of the HLA-DQB1*02 allelic variant (which is > 95%-96% in CD patients without risk factors, like type 1 diabetes mellitus comorbidity) might be exploited to consider a cost-effective and widened screening approach. If a sustainable strategy could be implemented through a low-cost targeted genetic test to detect the individual presence of HLA-DQB1*02 allele, an appropriate algorithm for serological screening in individuals resulting to be genetically predisposed to CD, might be considered.

Setup of Quantitative PCR for Oral Neisseria spp. Evaluation in Celiac Disease Diagnosis

Oropharyngeal microbiome evaluation highlights Neisseria abundance in active celiac patients

Are there new biomarkers of the gastroduodenal microbiota useful in the diagnosis of coeliac disease in children? A pilot study

Assessment of salivary microbiota profile as a potential diagnostic tool for pediatric celiac disease

Diagnosis of celiac disease on a gluten-free diet: a multicenter prospective quasi-experimental clinical study

Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study

Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study

Celiac disease-associated Neisseria flavescens decreases mitochondrial respiration in CaCo-2 epithelial cells: Impact of Lactobacillus paracasei CBA L74 on bacterial-induced cellular imbalance

A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE

A comprehensive map of microbial biomarkers along the gastrointestinal tract for celiac disease patients

Circulating MicroRNAs and Cytokines Associated with Celiac Disease

Computer-Based Diagnosis of Celiac Disease by Quantitative Processing of Duodenal Endoscopy Images

Carrier frequency of HLA-DQB1*02 allele in patients affected with celiac disease: A systematic review assessing the potential rationale of a targeted allelic genotyping as a first-line screening

Quantitative histology-based classification system for assessment of the intestinal mucosal histological changes in patients with celiac disease

Biogeographic Variation and Functional Pathways of the Gut Microbiota in Celiac Disease

Abnormalities in metabolic pathways in celiac disease investigated by the metabolic profiling of small intestinal mucosa, blood plasma and urine by NMR spectroscopy

Oral Health Impact Profile in Celiac Patients: Analysis of Recent Findings in a Literature Review

The Interaction Between Celiac Disease and Intestinal Microbiota

The metabonomic signature of celiac disease

Celiac Disease: The Importance of Studying the Duodenal Mucosa-Associated Microbiota